Subscribe: Market Wire - Medical and Healthcare: Medical Devices
http://img.marketwire.com/rss/mwMHMD.rss
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
cannabis  clinical  company  health  marketwired nov  marketwired november  marketwired  media  medical  nov  november  webinar 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Medical Devices

Marketwired - Medical Devices



Marketwired - Medical Devices



Last Build Date: Wed, 22 Nov 2017 16:18:34 EST

Copyright: Copyright: (C) Marketwired
 



U.S. FDA Advisory Panel Meetings: Strategies to Maximize Success, New Webinar Hosted by Xtalks

Wed, 22 Nov 2017 15:47:38 EST

TORONTO, ON--(Marketwired - November 22, 2017) - Often, US Food & Drug Administration (FDA) Advisory Panel meetings are the capstone to what is characteristically a long and arduous medical device development journey. While these meetings typically close with a voting session on a medical device's approvability, recent real-world experiences demonstrate that achieving a favorable set of panel votes does not always guarantee swift FDA approval of the medical device under consideration.




ORHub, Inc. (ORHB) Provides 2017 Business Highlights and Sets Special Warrant Exercise Price

Wed, 22 Nov 2017 12:09:17 EST

NEWPORT BEACH, CA--(Marketwired - Nov 22, 2017) - ORHub, Inc. (OTC: ORHB), an advanced digital software company focused on helping improve the bottom line of the surgical business and overall cost effectiveness of hospitals, today provides a business update and announces a special warrant exercise price of $0.35 per warrant for all Series.




Jacobson Pharma Announces FY2018 Interim Results

Wed, 22 Nov 2017 09:55:24 EST

Realizing Growth Strategies With Both Revenue and Net Profit Up; Declares Interim Dividend of HK0.9 cent per share




Northern Vine Labs Combines the Best of Abattis and Emerald Health -- CFN Media

Wed, 22 Nov 2017 09:53:13 EST

SEATTLE, WA--(Marketwired - Nov 22, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article covering the partnership between Abattis Bioceuticals Corp. (CSE: ATT) (CNSX: ATT) (CNSX: ATT.CN) (OTCQB: ATTBF) and Emerald Health Therapeutics Inc. (TSX VENTURE: EMH) (OTCQX: EMHTF) to run Northern Vine Laboratories as a joint venture, which promises to take advantage of a growing market for lab testing and extract products.




ESMO Celebrates Successful Completion Of 3rd ESMO Asia Congress In Singapore

Tue, 21 Nov 2017 21:00:00 EST

The momentum continues as experts around the world gather to advance cancer care




Cannabis Science Finalizes Acquisition of its First PRE ICO Dispensary in Los Angeles, California and Continues Negotiations to Close the Second Los Angeles Area Medical Marijuana Dispensary

Tue, 21 Nov 2017 11:29:51 EST

IRVINE, CA--(Marketwired - Nov 21, 2017) -  Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that its expansions plans are well underway as it has signed agreements to acquire and officially open the first Cannabis Science PRE ICO Medical Marijuana dispensary, in Los Angeles, California.




The Alliance for Regenerative Medicine Releases Q3 2017 Data Report, Highlighting Sector Trends and Metrics

Tue, 21 Nov 2017 10:57:39 EST

WASHINGTON, DC--(Marketwired - Nov 21, 2017) - The Alliance for Regenerative Medicine (ARM) released today its most recent quarterly data report, offering an in-depth look at cell therapy, gene therapy, tissue engineering and broader global regenerative medicine sector trends and metrics in the third quarter of 2017.




LogicStream Health Webinar Explores Clinical Process Improvement

Tue, 21 Nov 2017 09:00:00 EST

MINNEAPOLIS, MN--(Marketwired - Nov 21, 2017) - LogicStream Health announced today that registration is now open for its upcoming webinar, "Clinical Process Improvement - Better Process, Better Quality, Better Results," focusing on implementation of impactful clinical process improvement to enhance care and reduce costs. LogicStream Health Chief Medical Officer Brita Hansen, M.D., will host the 60-minute presentation and Q&A session, which takes place at 11:30 a.m. CST Wednesday, November 29.




Global Medical Information System: Characteristics & Implementation Approach, New Webinar Hosted by Xtalks

Tue, 21 Nov 2017 07:30:00 EST

TORONTO, ON--(Marketwired - November 21, 2017) - In a live session upcoming on Wednesday, December 6, 2017, Techsol, a global leader in life sciences, will present a webinar that will examine key characteristics of a global medical information management system and the critical factors that drive an optimized implementation and deployment strategy.




When Is Central Imaging Needed in Clinical Trials? New Webinar Hosted by Xtalks

Tue, 21 Nov 2017 07:00:00 EST

TORONTO, ON--(Marketwired - November 21, 2017) - On Wednesday, December 6, 2017 Xtalks will host a webinar that summarizes and highlights the various types of imaging and their role in the clinic and in research, with a perspective on the regulatory aspects that govern its use and practical aspects for pharma, biotech and contract research organizations.




SANUWAVE Health Reports Third Quarter Financial Results and Provides a Business Update

Mon, 20 Nov 2017 18:12:07 EST

SUWANEE, GA--(Marketwired - Nov 20, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the three and nine months ended September 30, 2017 on November 14 2017 and will provide a business update on a conference call at 10:00AM Eastern Time on Tuesday, November 21, 2017. 




Rennova Health Reports Third Quarter 2017 Financial Results

Mon, 20 Nov 2017 16:45:00 EST

WEST PALM BEACH, FL --(Marketwired - November 20, 2017) - Rennova Health, Inc. (OTCQB: RNVA) (OTCQB: RNVAW), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers that opened its first rural hospital in Oneida, Tennessee on August 8, 2017, reports financial results for the three and nine months ended September 30, 2017 and provides a business update.




Deciphering the Complexity of the Acute Leukemia Immunological Microenvironment with 3D Biology(TM) Technology, New Webinar Hosted by Xtalks

Mon, 20 Nov 2017 12:07:52 EST

TORONTO, ON--(Marketwired - November 20, 2017) - Join the live session on Tuesday, December 5, 2017 at 12pm EST to learn more about how the combined analysis of SNV, mRNA, and protein expression on the nCounter system enabled a comprehensive characterization of the molecular landscape of leukemia cells. Guest speakers include Doug Hinerfeld, Ph.D., Principal Product Application Scientist at NanoString Technologies, and Sergio Rutella, M.D., Ph.D., Professor of Cancer Immunotherapy, at John van Geest Cancer Research Centre, Nottingham Trent University.




mCig's eHesive Advertising Network Signed an Exclusive Agreement with Hosting Company FlameNetworks

Mon, 20 Nov 2017 09:56:52 EST

LAS VEGAS, NV--(Marketwired - Nov 20, 2017) - mCig, Inc. (OTCQB: MCIG), a diversified company servicing the legal cannabis markets, announced today that the company has entered into an agreement between OBITX, Inc., formerly known as GigeTech, Inc., a wholly owned subsidiary of MCIG and FlameNetworks to implement the proprietary eHesive Advertising Network with an Exclusive territory as an EU partner.




Milestone Scientific Announces Planned Launch of Instrument for Botox Delivery

Mon, 20 Nov 2017 09:03:35 EST

As popularity of cosmetic injection treatments expands, demand for safer, less painful and more accurate delivery systems grows




Advanced Proteome Therapeutics Expands Antibody-Drug Conjugate Collaboration

Mon, 20 Nov 2017 08:00:00 EST

VANCOUVER, BC--(Marketwired - November 20, 2017) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) a biotechnology company focused on developing superior targeted protein therapeutics, is expanding the collaboration with the National Research Council of Canada (NRC) and receiving support from its Industrial Research Assistance Program (NRC IRAP) to conduct key steps in development of APC's novel technology.




Improving Regulatory and Operational Performance in Orphan Drug Development, a New Webinar Presented by Premier Research and Hosted by Xtalks

Mon, 20 Nov 2017 07:00:00 EST

TORONTO, ON--(Marketwired - November 20, 2017) - Today more than ever, regulatory bodies are providing a progressive platform for rare disease drug development. Extensions to existing regulations and incentives and attempts to reduce orphan drug designation applications provide a collaborative environment for companies developing orphan drugs.




drchrono Commits to Putting iPad Pro Into the Hands of Physicians

Fri, 17 Nov 2017 10:44:59 EST

The iPad Pro is the future of clinical charting and revolutionizing today's medical practice; drchrono is enabling physicians with the iPad Pro




CFN Media Exclusive Onsite CEO Interview with Lifestyle Delivery Systems: Up and Running in a $5 Billion Market

Fri, 17 Nov 2017 09:00:00 EST

SEATTLE, WA--(Marketwired - Nov 17, 2017) -  CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an exclusive CEO interview and article covering Lifestyle Delivery Systems Inc. (CSE: LDS) (CNSX: LDS) (LDS.CN) (OTCQB: LDSYF), its new state of the art facility in Adelanto, California, and the potential for the company as California implements new regulations for adult-use of marijuana.




Future Farm Partners with Israeli Company to Develop Elite Cannabis Clones -- CFN Media

Fri, 17 Nov 2017 09:00:00 EST

SEATTLE, WA--(Marketwired - Nov 17, 2017) -  CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing the need to develop a wide variety of standardized cannabis plants for a vast array of potential applications, and the efforts of Future Farm Technologies Inc. (CSE: FFT) (CNSX: FFT) (CN.FFT) (OTCQB: FFRMF) to solve the problem.




Align Technology Expands Distribution for iTero Element(R)and Enhances Same-Day Dental Restorations With Glidewell Dental

Fri, 17 Nov 2017 08:30:00 EST

SAN JOSE, CA--(Marketwired - November 17, 2017) - Align Technology, Inc. (NASDAQ: ALGN) announced an agreement with Glidewell Dental to distribute the iTero Element® intraoral scanning system in North America with the newly unveiled glidewell.ioT In-Office Solution, a chairside restorative ecosystem designed to simplify the process of prescribing and delivering laboratory-quality dental restorations.




Intelligent Highway Solutions, Inc. Issues Shareholder Update

Thu, 16 Nov 2017 18:30:59 EST

SACRAMENTO, CA--(Marketwired - Nov 16, 2017) - Intelligent Highway Solutions, Inc. (OTCBB: IHSI), today updates shareholders on the status of your Company.




The Sequoia Project's Annual Meeting to Draw Health IT Leaders Nationwide to Discuss Data Sharing Progress and the Path Forward

Thu, 16 Nov 2017 09:28:07 EST

Event to be held December 5-6 in Gaylord National Harbor, Maryland




SANUWAVE Health to Host Upcoming Clinical and Science Symposium on Advanced Wound Care

Thu, 16 Nov 2017 09:00:00 EST

SUWANEE, GA--(Marketwired - Nov 16, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) today announces the Company's planned Clinical and Science Symposium on Advanced Wound Care to be held on December 8 and 9, 2017, in Atlanta, GA. This event will gather SANUWAVE's clinical researchers, science advisors, Key Opinion Leaders, and world-wide distributors to discuss extracorporeal shockwave technology as an advanced modality in the wound care field, its current applications in the medical field, and future applications in wound care and other medical needs. Medical professionals and distributors will be attending from Taiwan, Italy, Brazil, and South Korea as well as medical advisors from the U.S. SANUWAVE is pleased to have among its presenters Dr. Maria Siemionow, Professor of Orthopedics and Director of Microsurgery Research at the University of Illinois at Chicago College of Medicine and Dr. Ching-Jen Wang, Professor of Orthopaedic Surgery at the Chang Gung University College of Medicine and Chang Gung Memorial Hospital, Taiwan.




Time Magazine Names eSight 3 as One of the Best Inventions of 2017

Thu, 16 Nov 2017 08:38:39 EST

eSight is the only clinically validated device in existence that enables the legally blind to actually see, be mobile, work, study and engage in virtually all Activities of Daily Living




Cannabis Science Set to Launch its Online Community for Doctors, Patients, Industry Professionals Worldwide to Share Experiences and Expertise Using Cannabinoid Therapies for Various Critical Ailments, Palliative Care and Related Information

Thu, 16 Nov 2017 08:05:57 EST

IRVINE, CA--(Marketwired - Nov 16, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is proud to announce that next week the company will release its newest version of the Patient Access Center (PAC), an exclusive online community for social networking and information sharing platform. By bringing together Doctors, Patients, Industry Professionals, Lawyers, Scientists, Civil and Constitutional Rights Activists, Legalization Efforts Groups and many others, we are building a powerful knowledge center of real world data of successful treatment stories, formal clinical study information, to mobilizing large groups for upcoming events, or certain demographics that need help to help effective change for each area of concern or question.




BioCorRx Provides Business Update for the Third Quarter of 2017

Thu, 16 Nov 2017 08:00:00 EST

Investor Call to be held on Friday, November 17th at 2:00 PM ET




Zenosense, Inc.: MIDS Hybrid Strip - Successful Initial Test Results

Thu, 16 Nov 2017 07:30:00 EST

VALENCIA, SPAIN--(Marketwired - Nov 16, 2017) - Zenosense, Inc. (OTC PINK: ZENO) ("Zenosense", the "Company"), a healthcare technology company primarily focused on the development and commercialization of MIDS CardiacT, a Point of Care ("POC") handheld device for the early detection of certain cardiac event biomarkers to significantly accelerate the triage, diagnosis, treatment and disposition of patients reporting chest pain and with suspected acute myocardial infarction (heart attack), is pleased to announce that its MIDS Medical Limited joint venture ("MML") based at Sci-Tech, Daresbury (UK), has successfully completed initial testing of its "Hybrid Strip" system.




Titan Medical Reports First Use of Sport Surgical System at Columbia University Medical Center

Thu, 16 Nov 2017 07:30:00 EST

Completes critical surgical tasks integral to successful performance in gynecologic procedures